Loading clinical trials...
Loading clinical trials...
A Multicenter Open-Label Treatment Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita
Conditions
Interventions
PTX-022
Locations
1
United States
Minnesota Clinical Study Center
New Brighton, Minnesota, United States
Start Date
November 15, 2022
Primary Completion Date
October 1, 2023
Completion Date
November 1, 2023
Last Updated
December 9, 2022
NCT02321423
NCT05956314
NCT04520750
NCT01382511
Lead Sponsor
Palvella Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions